Tectonic Therapeutic, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TECX research report →
About the company
Tectonic Therapeutic, Inc. operates as a clinical-stage biotechnology firm dedicated to the identification and progression of biologic therapies, primarily therapeutic proteins and antibodies, that regulate the function of G-protein coupled receptors (GPCRs). The company leverages its proprietary GEODe technology platform to facilitate the discovery and development of these GPCR-targeted medicines.
- CEO
- Alise S. Reicin
- IPO
- 2018
- Employees
- 51
- HQ
- Watertown, MA, US
Price Chart
- Market Cap
- $715.71M
- P/E
- -8.50
- P/S
- 0.00
- P/B
- 3.09
- EV/EBITDA
- -6.00
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -32.33%
- ROIC
- -39.58%
- Revenue
- $0 · 0.00%
- Net Income
- $-74,151,000 · -27.89%
- EPS
- $-4.05 · -3.05%
- Op Income
- $-84,036,000
- FCF YoY
- -1.77%
- 52W High
- $38.12
- 52W Low
- $14.39
- 50D MA
- $29.49
- 200D MA
- $23.76
- Beta
- 0.10
- Avg Volume
- 201.82K
Get TickerSpark's AI analysis on TECX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 30, 26 | McNamara Peter | other | 172 |
| Jun 30, 26 | McNamara Peter | sell | 172 |
| Jun 30, 26 | McNamara Peter | other | 172 |
| Jun 20, 26 | REICIN ALISE | other | 924 |
| Jun 11, 26 | Lochner Daniel | other | 7,500 |
| Jun 9, 26 | SPRINGER TIMOTHY A | other | 10,200 |
| Jun 9, 26 | Tipirneni Praveen P. | other | 10,200 |
| Jun 9, 26 | Donenberg Phillip B. | other | 10,200 |
| Jun 9, 26 | Vitorovic Stefan | other | 10,200 |
| Jun 8, 26 | Chutter Jessica Caroline | other | 20,400 |
Our TECX coverage
Recent articles, reports, and earnings notes.
No research on TECX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate TECX report →Similar companies
Peers in the same neighborhood.